ETS2 and autoimmune disease: This variant appears to correlate with an increased ETS2 expression in PBMCs, supporting its functional role as a cis-eQTL that is likely mediated by altered transcription factor binding and chromatin accessibility, and highlighting the importance of non-coding regulatory variants in the pathogenesis of autoimmune diseases.